Hantz Financial Services’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
34,865
+2,995
+9% +$88.5K 0.02% 454
2026
Q1
$883K Buy
31,870
+9,432
+42% +$242K 0.01% 509
2025
Q4
$487K Buy
22,438
+4,809
+27% +$94.9K 0.01% 603
2025
Q3
$267K Buy
17,629
+3,315
+23% +$41K ﹤0.01% 669
2025
Q2
$161K Buy
14,314
+13,284
+1,290% +$144K ﹤0.01% 657
2025
Q1
$10K Buy
1,030
+427
+71% +$4.62K ﹤0.01% 968
2024
Q4
$7K Hold
603
﹤0.01% 858
2024
Q3
$7K Buy
603
+149
+33% +$1.7K ﹤0.01% 837
2024
Q2
$5K Hold
454
﹤0.01% 866
2024
Q1
$5K Buy
+454
New +$4.9K ﹤0.01% 943

Other funds holding ROIV

Hantz Financial Services's ROIV Position: Q2 2026 in Review

Hantz Financial Services increased its Roivant Sciences (ROIV) stake by 9.4% in Q2 2026, buying an estimated $88.5K and bringing the position to 34,865 shares worth $1.23M. The position accounts for 0.02% of the portfolio, ranked #454.

Hantz Financial Services first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Hantz Financial Services held 34,865 shares of Roivant Sciences worth $1.23M as of Q2 2026.
  • Hantz Financial Services bought 2,995 Roivant Sciences shares in Q2 2026, an estimated $88.5K.
  • Roivant Sciences made up 0.02% of Hantz Financial Services's portfolio in Q2 2026, its #454 holding.
  • Hantz Financial Services first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.